SFI
Susquehanna Fundamental Investments’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.73M | Sell |
178,906
-74,889
| -30% | -$3.23M | 0.21% | 139 |
|
|
2025
Q1 | $8.77M | Buy |
253,795
+15,800
| +7% | +$546K | 0.12% | 209 |
|
|
2024
Q4 | $6.53M | Buy |
+237,995
| New | +$6.53M | 0.09% | 272 |
|
|
2024
Q2 | $4.25M | Buy |
+167,839
| New | +$4.25M | 0.1% | 259 |
|
|
2024
Q1 | – | Sell |
-42,029
| Closed | -$1.7M | – | 668 |
|
|
2023
Q4 | $1.7M | Sell |
42,029
-71,081
| -63% | -$2.87M | 1.72% | 15 |
|
|
2023
Q3 | $2.98M | Hold |
113,110
| – | – | 0.19% | 119 |
|
|
2023
Q2 | $1.95M | Hold |
113,110
| – | – | 0.07% | 253 |
|
|
2023
Q1 | $1.88M | Hold |
113,110
| – | – | 0.04% | 388 |
|
|
2022
Q4 | $862K | Buy |
113,110
+97,510
| +625% | +$743K | 0.01% | 693 |
|
|
2022
Q3 | $155K | Buy |
+15,600
| New | +$155K | ﹤0.01% | 1294 |
|
|
2022
Q1 | $158K | Sell |
15,600
-19,900
| -56% | -$202K | ﹤0.01% | 1403 |
|
|
2021
Q4 | $592K | Buy |
+35,500
| New | +$592K | 0.02% | 849 |
|